Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Jan 15;9(1):e022776.
doi: 10.1136/bmjopen-2018-022776.

Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey

Affiliations
Multicenter Study

Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey

Dominique Dos Reis et al. BMJ Open. .

Abstract

Objectives: Cardiorenal syndrome (CRS) is the combination of acute heart failure syndrome (AHF) and renal dysfunction (creatinine clearance (CrCl) ≤60 mL/min). Real-life data were used to compare the management and outcome of AHF with and without renal dysfunction.

Design: Prospective, multicentre.

Setting: Twenty-six academic, community and regional hospitals in France.

Participants: 507 patients with AHF were assessed in two groups according to renal function: group 1 (patients with CRS (CrCl ≤60 mL/min): n=335) and group 2 (patients with AHF with normal renal function (CrCl >60 mL/min): n=172).

Results: Differences were observed (group 1 vs group 2) at admission for the incidence of chronic heart failure (56.42% vs 47.67%), use of furosemide (60.9% vs 52.91%), insulin (15.52% vs 9.3%) and amiodarone (14.33% vs 4.65%); additionally, more patients in group 1 carried a defibrillator (4.78% vs 0%), had ≥2 hospitalisations in the last year (15.52% vs 5.81%) and were under the care of a cardiologist (72.24% vs 61.63%). Clinical signs were broadly similar in each group. Brain-type natriuretic peptide (BNP) and BNP prohormone were higher in group 1 than group 2 (1157.5 vs 534 ng/L and 5120 vs 2513 ng/mL), and more patients in group 1 were positive for troponin (58.2% vs 44.19%), had cardiomegaly (51.04% vs 37.21%) and interstitial opacities (60.3% vs 47.67%). The only difference in emergency treatment was the use of nitrates, (higher in group 1 (21.9% vs 12.21%)). In-hospital mortality and the percentage of patients still hospitalised after 30 days were similar between groups, but the median stay was longer in group 1 (8 days vs 6 days).

Conclusions: Renal impairment in AHF should not limit the use of loop diuretics and/or vasodilators, but early assessment of pulmonary congestion and close monitoring of the efficacy of conventional therapies is encouraged to allow rapid and appropriate implementation of alternative therapies if necessary.

Keywords: acute heart Failure; ahf; cardio-renal syndrome; crs; real-life; renal dysfunction.

PubMed Disclaimer

Conflict of interest statement

Competing interests: CEK has received grants from Novartis (other than this work), Daiichy Sankyo and Boehringer Ingleheim. NP report has acted as a paid consultant for Vygon SA. SC reports personal fees from Novartis (other than this work). LF is an employee of RESCUe Network.

Figures

Figure 1
Figure 1
Patient disposition. DeFSSICA, Description de la Filière de Soins dans les Syndromes d’Insuffisance Cardiaque Aigue; HF, heart failure.

Similar articles

Cited by

References

    1. Sayago-Silva I, García-López F, Segovia-Cubero J. Epidemiology of heart failure in Spain over the last 20 years. Rev Esp Cardiol 2013;66:649–56. 10.1016/j.rec.2013.03.012 - DOI - PubMed
    1. Ferreira JP, Girerd N, Pellicori P, et al. . Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. BMC Med 2016;14:181 10.1186/s12916-016-0731-2 - DOI - PMC - PubMed
    1. Hillege HL, Girbes AR, de Kam PJ, et al. . Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203–10. 10.1161/01.CIR.102.2.203 - DOI - PubMed
    1. Damman K, Valente MA, Voors AA, et al. . Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 2014;35:455–69. 10.1093/eurheartj/eht386 - DOI - PubMed
    1. Ronco C, Haapio M, House AA, et al. . Cardiorenal syndrome. J Am Coll Cardiol 2008;52:1527–39. 10.1016/j.jacc.2008.07.051 - DOI - PubMed

Publication types

MeSH terms